{"id":"https://openalex.org/W4408161267","doi":"https://doi.org/10.1038/s42256-025-00991-2","title":"Data-driven federated learning in drug discovery with knowledge distillation","display_name":"Data-driven federated learning in drug discovery with knowledge distillation","publication_year":2025,"publication_date":"2025-03-05","ids":{"openalex":"https://openalex.org/W4408161267","doi":"https://doi.org/10.1038/s42256-025-00991-2"},"language":"en","primary_location":{"id":"doi:10.1038/s42256-025-00991-2","is_oa":false,"landing_page_url":"https://doi.org/10.1038/s42256-025-00991-2","pdf_url":null,"source":{"id":"https://openalex.org/S2912241403","display_name":"Nature Machine Intelligence","issn_l":"2522-5839","issn":["2522-5839"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Machine Intelligence","raw_type":"journal-article"},"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082247372","display_name":"Thierry Hanser","orcid":"https://orcid.org/0000-0002-0392-6154"},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Thierry Hanser","raw_affiliation_strings":["Lhasa Limited, Leeds, UK"],"raw_orcid":"https://orcid.org/0000-0002-0392-6154","affiliations":[{"raw_affiliation_string":"Lhasa Limited, Leeds, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046035604","display_name":"Ernst Ahlberg","orcid":"https://orcid.org/0000-0003-2050-9069"},"institutions":[{"id":"https://openalex.org/I4210106678","display_name":"M\u00f6lnlycke Health Care (Sweden)","ror":"https://ror.org/01pvzsz53","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210106678"]},{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Ernst Ahlberg","raw_affiliation_strings":["M\u00f6lnlycke Health Care, Gothenburg, Sweden","Predictive Compound ADME and Safety, Drug Safety and Metabolism, AstraZeneca IMED Biotech Unit, M\u00f6lndal, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M\u00f6lnlycke Health Care, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210106678"]},{"raw_affiliation_string":"Predictive Compound ADME and Safety, Drug Safety and Metabolism, AstraZeneca IMED Biotech Unit, M\u00f6lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110550239","display_name":"Alexander Amberg","orcid":"https://orcid.org/0000-0001-9923-0137"},"institutions":[{"id":"https://openalex.org/I4210138838","display_name":"Sanofi (Germany)","ror":"https://ror.org/03ytdtb31","country_code":"DE","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210138838"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Alexander Amberg","raw_affiliation_strings":["Preclinical Safety, Sanofi, Frankfurt, Germany"],"raw_orcid":"https://orcid.org/0000-0001-9923-0137","affiliations":[{"raw_affiliation_string":"Preclinical Safety, Sanofi, Frankfurt, Germany","institution_ids":["https://openalex.org/I4210138838"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104384142","display_name":"Lennart T. Anger","orcid":null},"institutions":[{"id":"https://openalex.org/I4210138838","display_name":"Sanofi (Germany)","ror":"https://ror.org/03ytdtb31","country_code":"DE","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210138838"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Lennart T. Anger","raw_affiliation_strings":["Computational Toxicologist, Genentech, Inc., South San Francisco, CA, USA","Preclinical Safety, Sanofi, Frankfurt, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Computational Toxicologist, Genentech, Inc., South San Francisco, CA, USA","institution_ids":[]},{"raw_affiliation_string":"Preclinical Safety, Sanofi, Frankfurt, Germany","institution_ids":["https://openalex.org/I4210138838"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083785539","display_name":"Chris Barber","orcid":"https://orcid.org/0000-0003-4220-1137"},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chris Barber","raw_affiliation_strings":["Lhasa Limited, Leeds, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lhasa Limited, Leeds, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064989100","display_name":"Richard Brennan","orcid":"https://orcid.org/0000-0002-0449-2730"},"institutions":[{"id":"https://openalex.org/I4210085864","display_name":"AVEO Oncology (United States)","ror":"https://ror.org/000mrza07","country_code":"US","type":"company","lineage":["https://openalex.org/I4210085864"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard J. Brennan","raw_affiliation_strings":["Preclinical Safety, Sanofi, Cambridge, MA, USA"],"raw_orcid":"https://orcid.org/0000-0002-0449-2730","affiliations":[{"raw_affiliation_string":"Preclinical Safety, Sanofi, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4210085864"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065033868","display_name":"Alessandro Brigo","orcid":"https://orcid.org/0000-0001-6860-9515"},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"Roche (Switzerland)","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Alessandro Brigo","raw_affiliation_strings":["Pharma Research and Early Development, Roche, Basel, Switzerland"],"raw_orcid":"https://orcid.org/0000-0001-6860-9515","affiliations":[{"raw_affiliation_string":"Pharma Research and Early Development, Roche, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003646193","display_name":"Annie Delaunois","orcid":"https://orcid.org/0000-0001-6345-7989"},"institutions":[{"id":"https://openalex.org/I85722119","display_name":"UCB Pharma (Belgium)","ror":"https://ror.org/01n029866","country_code":"BE","type":"company","lineage":["https://openalex.org/I85722119"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Annie Delaunois","raw_affiliation_strings":["Safety and Secondary Pharmacology, UCB Biopharma SRL, Braine L\u2019Alleud, Belgium"],"raw_orcid":"https://orcid.org/0000-0001-6345-7989","affiliations":[{"raw_affiliation_string":"Safety and Secondary Pharmacology, UCB Biopharma SRL, Braine L\u2019Alleud, Belgium","institution_ids":["https://openalex.org/I85722119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002718458","display_name":"Susanne Glowienke","orcid":null},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Susanne Glowienke","raw_affiliation_strings":["Novartis Institutes for Biological Research (NIBR), Novartis Pharma AG, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Institutes for Biological Research (NIBR), Novartis Pharma AG, Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031183535","display_name":"Nigel Greene","orcid":"https://orcid.org/0000-0003-0433-4596"},"institutions":[{"id":"https://openalex.org/I4210092243","display_name":"AstraZeneca (South Korea)","ror":"https://ror.org/00h1xaa75","country_code":"KR","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210092243"]},{"id":"https://openalex.org/I4210129988","display_name":"Arrien Pharmaceuticals (United States)","ror":"https://ror.org/02x59h163","country_code":"US","type":"company","lineage":["https://openalex.org/I4210129988"]}],"countries":["KR","US"],"is_corresponding":false,"raw_author_name":"Nigel Greene","raw_affiliation_strings":["Imaging & Data Analytics, Clinical Pharmacology & Safety Sciences, AstraZeneca, Waltham, MA, USA","Toxicology, Recursion Pharmaceuticals, Salt Lake City, UT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imaging & Data Analytics, Clinical Pharmacology & Safety Sciences, AstraZeneca, Waltham, MA, USA","institution_ids":["https://openalex.org/I4210092243"]},{"raw_affiliation_string":"Toxicology, Recursion Pharmaceuticals, Salt Lake City, UT, USA","institution_ids":["https://openalex.org/I4210129988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053002300","display_name":"Laura Johnston","orcid":null},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura Johnston","raw_affiliation_strings":["Lhasa Limited, Leeds, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lhasa Limited, Leeds, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078316788","display_name":"Daniel K\u00fchn","orcid":"https://orcid.org/0000-0002-0550-4174"},"institutions":[{"id":"https://openalex.org/I164928964","display_name":"Merck (Germany)","ror":"https://ror.org/04b2dty93","country_code":"DE","type":"company","lineage":["https://openalex.org/I164928964"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Daniel Kuhn","raw_affiliation_strings":["Global Computational Chemistry and Biology, Merck Healthcare KGaA, Darmstadt, Germany"],"raw_orcid":"https://orcid.org/0000-0002-0550-4174","affiliations":[{"raw_affiliation_string":"Global Computational Chemistry and Biology, Merck Healthcare KGaA, Darmstadt, Germany","institution_ids":["https://openalex.org/I164928964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019936542","display_name":"Lara Kuhnke","orcid":"https://orcid.org/0000-0002-4918-0132"},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Lara Kuhnke","raw_affiliation_strings":["Pharmaceuticals, R&D, Computational Molecular Design, Bayer AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceuticals, R&D, Computational Molecular Design, Bayer AG, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058896572","display_name":"Jean-Fran\u00e7ois Marchaland","orcid":null},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jean-Fran\u00e7ois Marchaland","raw_affiliation_strings":["Lhasa Limited, Leeds, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lhasa Limited, Leeds, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020291933","display_name":"Wolfgang Muster","orcid":"https://orcid.org/0000-0002-9832-6257"},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"Roche (Switzerland)","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Wolfgang Muster","raw_affiliation_strings":["Pharma Research and Early Development, Roche, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Research and Early Development, Roche, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006580790","display_name":"Jeffrey Plante","orcid":"https://orcid.org/0000-0001-6606-1920"},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey Plante","raw_affiliation_strings":["Lhasa Limited, Leeds, UK"],"raw_orcid":"https://orcid.org/0000-0001-6606-1920","affiliations":[{"raw_affiliation_string":"Lhasa Limited, Leeds, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013173045","display_name":"Friedrich Rippmann","orcid":"https://orcid.org/0000-0002-4604-9251"},"institutions":[{"id":"https://openalex.org/I164928964","display_name":"Merck (Germany)","ror":"https://ror.org/04b2dty93","country_code":"DE","type":"company","lineage":["https://openalex.org/I164928964"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Friedrich Rippmann","raw_affiliation_strings":["Global Computational Chemistry and Biology, Merck Healthcare KGaA, Darmstadt, Germany"],"raw_orcid":"https://orcid.org/0000-0002-4604-9251","affiliations":[{"raw_affiliation_string":"Global Computational Chemistry and Biology, Merck Healthcare KGaA, Darmstadt, Germany","institution_ids":["https://openalex.org/I164928964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036561799","display_name":"Yogesh Sabnis","orcid":null},"institutions":[{"id":"https://openalex.org/I85722119","display_name":"UCB Pharma (Belgium)","ror":"https://ror.org/01n029866","country_code":"BE","type":"company","lineage":["https://openalex.org/I85722119"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Yogesh Sabnis","raw_affiliation_strings":["Safety and Secondary Pharmacology, UCB Biopharma SRL, Braine L\u2019Alleud, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Safety and Secondary Pharmacology, UCB Biopharma SRL, Braine L\u2019Alleud, Belgium","institution_ids":["https://openalex.org/I85722119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102966370","display_name":"Friedemann Schmidt","orcid":"https://orcid.org/0000-0003-0265-0974"},"institutions":[{"id":"https://openalex.org/I4210138838","display_name":"Sanofi (Germany)","ror":"https://ror.org/03ytdtb31","country_code":"DE","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210138838"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Friedemann Schmidt","raw_affiliation_strings":["Preclinical Safety, Sanofi, Frankfurt, Germany"],"raw_orcid":"https://orcid.org/0000-0003-0265-0974","affiliations":[{"raw_affiliation_string":"Preclinical Safety, Sanofi, Frankfurt, Germany","institution_ids":["https://openalex.org/I4210138838"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029204349","display_name":"Ruud van Deursen","orcid":"https://orcid.org/0000-0002-8124-7325"},"institutions":[{"id":"https://openalex.org/I2801043613","display_name":"Firmenich (Switzerland)","ror":"https://ror.org/04d9v0a44","country_code":"CH","type":"company","lineage":["https://openalex.org/I2801043613"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Ruud van Deursen","raw_affiliation_strings":["AI & Modeling, DSM-Firmenich AG, Geneva, Switzerland","Lhasa Limited, Leeds, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AI & Modeling, DSM-Firmenich AG, Geneva, Switzerland","institution_ids":["https://openalex.org/I2801043613"]},{"raw_affiliation_string":"Lhasa Limited, Leeds, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041238648","display_name":"St\u00e9phane Werner","orcid":null},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"St\u00e9phane Werner","raw_affiliation_strings":["Lhasa Limited, Leeds, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lhasa Limited, Leeds, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045384302","display_name":"Angela White","orcid":"https://orcid.org/0000-0001-5725-7913"},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I2800110054","display_name":"Age UK","ror":"https://ror.org/050x9d346","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2800110054"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Angela White","raw_affiliation_strings":["Computational Toxicology, GlaxoSmithKline (GSK), Stevenage, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Computational Toxicology, GlaxoSmithKline (GSK), Stevenage, UK","institution_ids":["https://openalex.org/I2800110054","https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082222979","display_name":"Joerg Wichard","orcid":"https://orcid.org/0000-0002-6846-7446"},"institutions":[{"id":"https://openalex.org/I4210092770","display_name":"Cracow University of Technology","ror":null,"country_code":"PL","type":null,"lineage":["https://openalex.org/I4210092770"]},{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE","PL"],"is_corresponding":false,"raw_author_name":"Joerg Wichard","raw_affiliation_strings":["Computational Chemistry, Selvita S.A, Cracow, Poland","Pharmaceuticals, R&D, Computational Molecular Design, Bayer AG, Berlin, Germany"],"raw_orcid":"https://orcid.org/0000-0002-6846-7446","affiliations":[{"raw_affiliation_string":"Computational Chemistry, Selvita S.A, Cracow, Poland","institution_ids":["https://openalex.org/I4210092770"]},{"raw_affiliation_string":"Pharmaceuticals, R&D, Computational Molecular Design, Bayer AG, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045218076","display_name":"Tomoya Yukawa","orcid":"https://orcid.org/0000-0003-3394-0798"},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomoya Yukawa","raw_affiliation_strings":["Chemical Toxicology, Takeda Pharmaceutical Company, Ltd, Fujisawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Toxicology, Takeda Pharmaceutical Company, Ltd, Fujisawa, Japan","institution_ids":["https://openalex.org/I44892455"]}]}],"institutions":[],"countries_distinct_count":9,"institutions_distinct_count":24,"corresponding_author_ids":["https://openalex.org/A5082247372"],"corresponding_institution_ids":[],"apc_list":{"value":9750,"currency":"EUR","value_usd":11690},"apc_paid":null,"fwci":44.6483,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.99773266,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"7","issue":"3","first_page":"423","last_page":"436"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10764","display_name":"Privacy-Preserving Technologies in Data","score":0.9969000220298767,"subfield":{"id":"https://openalex.org/subfields/1702","display_name":"Artificial Intelligence"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10764","display_name":"Privacy-Preserving Technologies in Data","score":0.9969000220298767,"subfield":{"id":"https://openalex.org/subfields/1702","display_name":"Artificial Intelligence"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12072","display_name":"Machine Learning and Algorithms","score":0.9836000204086304,"subfield":{"id":"https://openalex.org/subfields/1702","display_name":"Artificial Intelligence"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11636","display_name":"Artificial Intelligence in Healthcare and Education","score":0.9592000246047974,"subfield":{"id":"https://openalex.org/subfields/2718","display_name":"Health Informatics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug","display_name":"Drug","score":0.6238487362861633},{"id":"https://openalex.org/keywords/distillation","display_name":"Distillation","score":0.5295026302337646},{"id":"https://openalex.org/keywords/computer-science","display_name":"Computer science","score":0.45224815607070923},{"id":"https://openalex.org/keywords/drug-discovery","display_name":"Drug discovery","score":0.42772865295410156},{"id":"https://openalex.org/keywords/business","display_name":"Business","score":0.4214932322502136},{"id":"https://openalex.org/keywords/medicine","display_name":"Medicine","score":0.23668813705444336},{"id":"https://openalex.org/keywords/pharmacology","display_name":"Pharmacology","score":0.20096945762634277},{"id":"https://openalex.org/keywords/chemistry","display_name":"Chemistry","score":0.16340085864067078},{"id":"https://openalex.org/keywords/chromatography","display_name":"Chromatography","score":0.11764079332351685}],"concepts":[{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6238487362861633},{"id":"https://openalex.org/C204030448","wikidata":"https://www.wikidata.org/wiki/Q101017","display_name":"Distillation","level":2,"score":0.5295026302337646},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.45224815607070923},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.42772865295410156},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.4214932322502136},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.23668813705444336},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.20096945762634277},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.16340085864067078},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.11764079332351685},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1038/s42256-025-00991-2","is_oa":false,"landing_page_url":"https://doi.org/10.1038/s42256-025-00991-2","pdf_url":null,"source":{"id":"https://openalex.org/S2912241403","display_name":"Nature Machine Intelligence","issn_l":"2522-5839","issn":["2522-5839"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Machine Intelligence","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/2","display_name":"Zero hunger","score":0.6899999976158142}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":57,"referenced_works":["https://openalex.org/W1534477342","https://openalex.org/W1930624869","https://openalex.org/W1988037271","https://openalex.org/W2002009218","https://openalex.org/W2012930217","https://openalex.org/W2021748110","https://openalex.org/W2096541451","https://openalex.org/W2109426455","https://openalex.org/W2109553965","https://openalex.org/W2114043871","https://openalex.org/W2151697120","https://openalex.org/W2165698076","https://openalex.org/W2269544137","https://openalex.org/W2412446857","https://openalex.org/W2473418344","https://openalex.org/W2530417694","https://openalex.org/W2535690855","https://openalex.org/W2541884796","https://openalex.org/W2549144853","https://openalex.org/W2804885211","https://openalex.org/W2903471046","https://openalex.org/W2914563121","https://openalex.org/W2976398475","https://openalex.org/W2980216952","https://openalex.org/W3012501605","https://openalex.org/W3028537074","https://openalex.org/W3086590218","https://openalex.org/W3086809868","https://openalex.org/W3097145107","https://openalex.org/W3102031770","https://openalex.org/W3107100345","https://openalex.org/W3119760211","https://openalex.org/W3129886642","https://openalex.org/W3132400453","https://openalex.org/W3141518839","https://openalex.org/W3156548180","https://openalex.org/W3186401068","https://openalex.org/W3196371845","https://openalex.org/W3202840499","https://openalex.org/W4200163348","https://openalex.org/W4200380626","https://openalex.org/W4212883601","https://openalex.org/W4220738117","https://openalex.org/W4224227775","https://openalex.org/W4226461837","https://openalex.org/W4282962298","https://openalex.org/W4297687186","https://openalex.org/W4312592506","https://openalex.org/W4317952770","https://openalex.org/W4321014289","https://openalex.org/W4385851145","https://openalex.org/W4386256707","https://openalex.org/W4392913518","https://openalex.org/W4394839129","https://openalex.org/W6747732332","https://openalex.org/W6771536673","https://openalex.org/W6930570332"],"related_works":["https://openalex.org/W4391375266","https://openalex.org/W2899084033","https://openalex.org/W2748952813","https://openalex.org/W2390279801","https://openalex.org/W4391913857","https://openalex.org/W2358668433","https://openalex.org/W4396701345","https://openalex.org/W2376932109","https://openalex.org/W2001405890","https://openalex.org/W4396696052"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":13}],"updated_date":"2026-05-03T08:25:01.440150","created_date":"2025-10-10T00:00:00"}